OBJECTIVE: Genome-wide copy number variation (CNV) analyses have associated the 10q11.22 CNV with obesity. As the NPY4R gene is the most interesting candidate gene in this region, it was hypothesized that both genetic and structural variation in NPY4R might be implicated in the pathogenesis of obesity. METHODS: In the first part of this study, 326 children and adolescents with obesity and 298 healthy lean individuals were screened for CNV in the NPY4R-containing chr.10q11.22 region. In the second part of this study, a mutation screen for variants in the NPY4R coding region was performed in 356 children and adolescents with obesity and 337 healthy lean adults. RESULTS: Our CNV analysis demonstrated a significantly higher frequency of NPY4R containing 10q11.22 CNV loss in the patient population (P = 0.0003), while CNV gain in this region was more prevalent in the control population (P = 0.031). Mutation analysis resulted in the identification of 15 rare non-synonymous heterozygous variants. For two variants that could only be identified in the patient population, receptor dysfunction and thus a pathogenic effect were demonstrated. CONCLUSIONS: In conclusion, these data support an essential role for genetic and structural variation within the NPY4R gene in the pathogenesis of obesity.
OBJECTIVE: Genome-wide copy number variation (CNV) analyses have associated the 10q11.22 CNV with obesity. As the NPY4R gene is the most interesting candidate gene in this region, it was hypothesized that both genetic and structural variation in NPY4R might be implicated in the pathogenesis of obesity. METHODS: In the first part of this study, 326 children and adolescents with obesity and 298 healthy lean individuals were screened for CNV in the NPY4R-containing chr.10q11.22 region. In the second part of this study, a mutation screen for variants in the NPY4R coding region was performed in 356 children and adolescents with obesity and 337 healthy lean adults. RESULTS: Our CNV analysis demonstrated a significantly higher frequency of NPY4R containing 10q11.22 CNV loss in the patient population (P = 0.0003), while CNV gain in this region was more prevalent in the control population (P = 0.031). Mutation analysis resulted in the identification of 15 rare non-synonymous heterozygous variants. For two variants that could only be identified in the patient population, receptor dysfunction and thus a pathogenic effect were demonstrated. CONCLUSIONS: In conclusion, these data support an essential role for genetic and structural variation within the NPY4R gene in the pathogenesis of obesity.
Authors: Kamal Mandal; Samuel L Bader; Pankaj Kumar; Dipankar Malakar; David S Campbell; Bhola Shankar Pradhan; Rajesh K Sarkar; Neerja Wadhwa; Souvik Sensharma; Vaibhav Jain; Robert L Moritz; Subeer S Majumdar Journal: DNA Res Date: 2017-04-01 Impact factor: 4.458
Authors: Man Li; Jacob Carey; Stephen Cristiano; Katalin Susztak; Josef Coresh; Eric Boerwinkle; Wen Hong L Kao; Terri H Beaty; Anna Köttgen; Robert B Scharpf Journal: PLoS One Date: 2017-01-30 Impact factor: 3.240
Authors: Kateryna Shebanits; Johanna C Andersson-Assarsson; Ingrid Larsson; Lena M S Carlsson; Lars Feuk; Dan Larhammar Journal: PLoS One Date: 2018-04-05 Impact factor: 3.752
Authors: Kateryna Shebanits; Torsten Günther; Anna C V Johansson; Khurram Maqbool; Lars Feuk; Mattias Jakobsson; Dan Larhammar Journal: BMC Biotechnol Date: 2019-06-04 Impact factor: 2.563
Authors: Paola León-Mimila; Hugo Villamil-Ramírez; Blanca E López-Contreras; Sofía Morán-Ramos; Luis R Macias-Kauffer; Víctor Acuña-Alonzo; Blanca E Del Río-Navarro; Jorge Salmerón; Rafael Velazquez-Cruz; Teresa Villarreal-Molina; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros Journal: Nutrients Date: 2018-11-01 Impact factor: 5.717
Authors: Lauren A Stone; Matthew J Girgenti; Jiawei Wang; Dingjue Ji; Hongyu Zhao; John H Krystal; Ronald S Duman Journal: Int J Neuropsychopharmacol Date: 2021-02-15 Impact factor: 5.176